What appears on a scan as a simple, harmless cyst may actually be a structural footprint of a deeper metabolic crisis.
Most doctors have said the same reassuring words to patients:
“It’s just a simple cyst. Nothing to worry about.”
Radiology reports frequently describe cysts in organs such as the kidneys, liver, pancreas, and thyroid. In most cases, these fluid-filled sacs are considered benign incidental findings, minor anatomical curiosities discovered during scans performed for unrelated reasons.
For many years, I believed that reassurance without hesitation.
Then one day, medicine became personal.
A cyst in my thyroid gland suddenly ruptured, causing rapid bleeding into the tissues of my neck. Within minutes, the swelling began compressing my airway, and breathing became difficult. I was fortunate to be in the hospital and was rushed immediately to the operating theatre, where surgeons evacuated the blood.
But the crisis did not end there. The cyst bled again, and my condition deteriorated rapidly. I spent seven days in the intensive care unit before stabilising.
That experience changed the way I think about cysts and about medicine itself.
It forced me to reconsider a fundamental question we rarely ask:
Why do cysts form in the first place?
That question ultimately pushed me toward Functional Medicine, where the focus shifts from simply identifying structural abnormalities to understanding the biological forces that create them.
One of those forces is metabolic dysfunction.
The Metabolic Environment: The Soil in Which Disease Grows
Disease rarely appears spontaneously. It develops within the body’s biological environment.
A useful analogy comes from agriculture. Seeds cannot grow unless the soil provides the right conditions. Similarly, many diseases develop only when the internal metabolic environment becomes favourable.
Modern lifestyles have created precisely such an environment. Metabolic syndrome, characterised by insulin resistance, abdominal obesity, high blood pressure, and chronic inflammation, has become increasingly common worldwide.
These metabolic disturbances change how cells behave. Energy production becomes inefficient, growth signals become abnormal, and tissues gradually lose their structural balance.
Under these conditions, the body becomes more prone to the development of structural abnormalities, including fluid-filled cysts.
What Exactly Is a Cyst?
At its simplest, a cyst is a sac filled with fluid and surrounded by a thin wall of tissue.
A helpful mental image is of a mild burn forming a bubble beneath the skin. Initially, the bubble is small and almost invisible. But if fluid continues to accumulate, the bubble expands and begins to distort the surface.
Inside the body, cysts behave in much the same way. They can form in organs such as:
- Kidneys
- Liver
- Pancreas
- Thyroid
- Ovaries
Many remain small and harmless. But others enlarge, multiply, and begin compressing surrounding tissues.
In diseases such as polycystic kidney disease (PKD), cysts can eventually replace large portions of normal organ structure.
The Plumbing Problem: When Metabolic Pressure Builds
Another way to visualise cyst formation is to imagine the body as a complex plumbing network.
In a well-functioning system, fluid flows smoothly through pipes and channels. But when pressure builds, or drainage pathways become impaired, water begins to collect in places it shouldn’t.
Something similar may occur inside the body.
Metabolic syndrome alters cellular signalling pathways that control fluid transport, tissue growth, and structural organisation. Insulin resistance and oxidative stress disrupt normal cell behaviour, allowing fluid pockets to gradually expand into cysts.
This process can be seen in acquired cystic kidney disease, where individuals with metabolic disturbances and chronic kidney disease develop numerous renal cysts over time.
In other words, cysts may sometimes represent the structural footprint of deeper metabolic stress.
The Hidden Link: Insulin Resistance and Fatty Organs
Insulin resistance, the central feature of metabolic syndrome, affects nearly every organ in the body.
When insulin signalling becomes impaired:
- Cells accumulate excess fat
- Inflammation increases
- Abnormal growth pathways are activated
This metabolic environment contributes to conditions such as fatty liver disease, which has now become the most common chronic liver condition worldwide.
Fatty infiltration of organs alters tissue structure and cellular signalling, creating conditions that increase the likelihood of cyst formation.
Some researchers have proposed that cystic disease and fatty organ disease may share common metabolic pathways, linking them to the broader epidemic of metabolic dysfunction.
How Cysts Gradually Damage Organs
Many cysts remain harmless. Problems arise when they grow larger or multiply.
Progressive Organ Dysfunction
The kidneys illustrate this process clearly.
Each kidney contains millions of microscopic filtration units called nephrons, which continuously filter and cleanse the blood.
You can imagine the kidney as a dense sponge made of tiny filters.
As cysts enlarge, they compress and gradually destroy these filtration units. Over time, this leads to:
- Declining kidney filtration
- Reduced estimated glomerular filtration rate (eGFR)
- Progressive kidney failure
Clinical studies show that multiple renal cysts larger than approximately 1.5 cm are associated with reduced kidney function.
In advanced cases, cyst expansion can lead to end-stage renal disease, requiring dialysis or transplantation.
The liver can also be affected. Large liver cysts may cause hepatomegaly (liver enlargement) and distort the organ’s internal architecture or obstruct the biliary system.
High Blood Pressure: A Hormonal Domino Effect
Kidney cysts can also activate the Renin–Angiotensin–Aldosterone System (RAAS).
When cysts compress blood vessels inside the kidney, the organ senses reduced blood flow. It responds by releasing renin, triggering a cascade of hormones that raise blood pressure.
While this mechanism evolved to protect us during dehydration or blood loss, chronic activation leads to persistent hypertension.
This increases the risk of:
- Cardiovascular disease
- Stroke
- Further kidney damage
Pressure Symptoms: When Organs Run Out of Space
As cysts enlarge, they behave like inflating balloons inside a rigid container.
This pressure can produce:
- Abdominal or back pain
- Abdominal swelling
- Digestive discomfort
- Early satiety (feeling full after small meals)
Large cysts may physically displace nearby organs, contributing to chronic discomfort.
Acute and Dangerous Complications
Occasionally, cysts can cause sudden, dramatic medical emergencies.
Rupture or bleeding
A cyst may suddenly rupture or bleed. In the kidneys, this often causes blood in the urine (haematuria).
In rare situations, such as the thyroid cyst that nearly suffocated me, bleeding occurs in confined spaces and threatens vital structures like the airway.
Obstruction
Large cysts can block urine flow, leading to hydronephrosis, a swelling of the kidney caused by trapped urine.
Infection
Cysts may become infected, leading to abscesses that cause fever, severe pain, and systemic illness.
A Systemic Condition, Not Just a Local Problem
Cystic diseases often affect multiple organs.
For example:
- Individuals with polycystic kidney disease have a higher risk of brain aneurysms, dangerous balloon-like bulges in blood vessels.
- Up to one quarter of adults with PKD develop heart valve abnormalities, particularly mitral valve prolapse.
These findings suggest that cyst formation may reflect a broader systemic disorder involving metabolism, vascular biology, and connective tissue integrity.
Increased Risk of Cancer
Patients with acquired cystic kidney disease have an increased risk of renal cell carcinoma.
Although the absolute risk remains relatively low, this association highlights the importance of periodic imaging and monitoring of large cysts.
Can Metabolic Health Influence Cyst Development?
Traditional medicine often focuses on treating cysts only when they cause symptoms.
Functional Medicine asks a deeper question:
What internal conditions allowed these cysts to develop in the first place?
Improving metabolic health may help reduce the biological forces that promote cyst formation.
Important factors include:
- Improving insulin sensitivity
- Reducing chronic inflammation
- Controlling blood pressure
- Supporting mitochondrial energy production
- Maintaining a healthy body weight
Lifestyle strategies that support metabolic health include:
- Regular physical activity
- Anti-inflammatory nutrition
- Reducing refined carbohydrates and processed foods
- Improving sleep quality
- Managing stress
While these approaches may not eliminate existing cysts, they can influence the metabolic terrain in which cysts grow.
A Final Reflection
For most people, a simple cyst truly is harmless.
But biology is rarely simple.
Sometimes the structures we see on scans are not random findings but subtle signals from the body that indicate deeper metabolic stress.
My own experience taught me that a cyst can be far more than a harmless bubble. It can be a reminder that the body is an interconnected system in which structural changes often reflect underlying biological forces.
Understanding those forces may allow us to move beyond simply observing cysts toward preventing the metabolic conditions that allow them to develop in the first place.
If you found this discussion useful, you may be interested in my book, “Your Metabolic Shift”, which explores these concepts in greater depth.
References
Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007.
Grantham JJ. Clinical practice: Autosomal dominant polycystic kidney disease. New England Journal of Medicine. 2008.
Harris PC, Torres VE. Genetic mechanisms and signalling pathways in polycystic kidney disease. Journal of Clinical Investigation. 2014.
Rule AD et al. Association between simple renal cysts and kidney function. Kidney International. 2012.
Chapman AB et al. Kidney volume and functional outcomes in polycystic kidney disease. Kidney International. 2003.
Schrier RW et al. Hypertension in autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology. 2014.
Qian Q. Isolated polycystic liver disease. Advances in Chronic Kidney Disease. 2010.
Chebib FT, Torres VE. Recent advances in the management of autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology. 2018.
Lanktree MB, Haghighi A, et al. Prevalence estimates of polycystic kidney and liver disease by population sequencing. Journal of the American Society of Nephrology. 2018.
Bae KT, Grantham JJ. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nature Reviews Nephrology. 2021.
Torres VE, Harris PC. Strategies targeting cAMP signalling in polycystic kidney disease. Kidney International. 2022.
